SCHEMBL6133051

SCHEMBL6133051

CS(=O)(=O)OCCC#Cc1cccnc1

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 5/20 0.55
CHRNA4 P43681 5/20 0.55
CYP2A6 P11509 4/20 0.51
CYP2C9 P11712 3/20 0.51
CYP2B6 P20813 3/20 0.51
CYP2C19 P33261 3/20 0.51
CYP2E1 P05181 2/20 0.50
CYP3A4 P08684 2/20 0.50
CYP2D6 P10635 2/20 0.50
CYP1A2 P05177 1/20 0.49
CYP2C8 P10632 1/20 0.49
DRD2 P14416 1/20 0.39
DRD4 P21917 1/20 0.39
DRD3 P35462 1/20 0.39
ERN1 O75460 1/20 0.39
GRM5 P41594 1/20 0.38
FFAR1 O14842 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7054843 0.77 CHRNB2 (0.55) CHRNB2CHRNA4CYP2A6CYP2C9CYP2B6
SCHEMBL14085289 0.75 CHRNB2 (0.69) CHRNB2CHRNA4CYP2A6CYP2C9CYP2B6
SCHEMBL5376053 0.75 CHRNB2 (0.63) CHRNB2CHRNA4CYP2A6CYP2C9CYP2B6
SCHEMBL30707971 0.75 CYP2A6 (0.58) CHRNB2CHRNA4CYP2A6CYP2C9CYP2B6
SCHEMBL29271410 0.75 CHRNB2 (0.55) CHRNB2CHRNA4CYP2A6CYP2C9CYP2B6
SCHEMBL3044684 0.73 CHRNB2 (0.70) CHRNB2CHRNA4CYP2A6CYP2C9CYP2B6
SCHEMBL11477234 0.73 PTPN2 (0.37) DRD2FFAR1
SCHEMBL103437 0.72 GRM5 (0.44) CYP1A2GRM5FFAR1
SCHEMBL15432604 0.72 KMT2A (0.40) FFAR1
SCHEMBL3673693 0.72 CHRNB2 (0.69) CHRNB2CHRNA4CYP2A6CYP2C9CYP2B6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6924278-B2 Heterocyclic carboxy amines such as (2R)-1-[3,5-Bis(trifluoromethyl)benzoyl]-4-[4-((3S)-3-ethylmorpholino)-2-butynyl]-2-[(1H-indol-3-yl)methyl]piperazine, used as substance P and neurokinin antagonist for prophylaxis of diseases FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-08-02 US disclosed
US-20050027121-A1 Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-02-03 US disclosed
US-20030114668-A1 AROYL-PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS TACHYKININ ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-06-19 US disclosed
EP-0993457-A1 AROYL-PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS TACHYKININ ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-04-19 EP disclosed
WO-1998057954-A1 AROYL-PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS TACHYKININ ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050027121-A1 Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists TAC3, TACR1, SSTR5 CHRNB2 549/4885CHRNA4 543/4885CYP2A6 2814/4885
US-20030114668-A1 AROYL-PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS TACHYKININ ANTAGONISTS TACR1, NPSR1, SSTR2 CHRNB2 461/4885CHRNA4 666/4885CYP2A6 2414/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.